Clinical Trial Update: Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating phenformin in combination with a BRAF inhibitor and a MEK inhibitor for patients with BRAF-muta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BRAF inhibitor
• MEK inhibitor
• Phenformin (phenformin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma | Phase 1 | Status: COMPLETED